DDOST and metabolic dysfunction-associated steatohepatitis: Overexpression of Nrf2 in the hepatocytes blocks AGER1 decrease and reduces the advanced glycation end-product levels, in addition to suppressing inflammation and fibrosis in the mouse model of non-alcoholic steatohepatitis (NASH) (Dehnad et al., 2020).